Results 1 to 10 of about 6,514,101 (424)

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

open access: yesEuropean Heart Journal, 2021
An engaging session on the newly revised European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) was conducted on the first day of the 2021 ESC virtual congress.
T. McDonagh   +30 more
semanticscholar   +2 more sources

Heart Failure [PDF]

open access: yesThe Scientific World Journal, 2014
Essential facts Heart failure affects about 900,000 people in the UK. The condition can affect people of all ages, but it is more common in older people, with more than half of all patients over the age of 75. It is caused by the heart failing to pump enough blood around the body at the right pressure, usually because the heart muscle has become too ...
Yanggan Wang, Yanzong Yang, Xun Ai
openaire   +5 more sources

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients

open access: yesTransplantation Direct, 2022
Background. A pulmonary capillary wedge pressure (PCWP) >18 mm Hg following volume load has been proposed as a partition value for the detection of heart failure with preserved ejection fraction. As hemodynamic changes in filling pressures (FP) have been
Monika Kobediona, MD   +10 more
doaj   +1 more source

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

open access: yesCirculation, 2022
AIM The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart ...
P. Heidenreich   +25 more
semanticscholar   +1 more source

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction ...
S. Anker   +40 more
semanticscholar   +1 more source

Selection of Comprehensive Assessment Categories Based on the International Classification of Functioning, Disability, and Health for Elderly Patients with Heart Failure: A Delphi Survey among Registered Instructors of Cardiac Rehabilitation

open access: yesOccupational Therapy International, 2021
The development of a comprehensive assessment tool based on the International Classification of Functioning, Disability, and Health (ICF) for elderly patients with heart failure is urgently required.
Shigehito Shiota   +8 more
doaj   +1 more source

Moderate Aortic Stenosis in Patients With Heart Failure

open access: yesKorean Circulation Journal, 2022
Author's summary Moderate aortic stenosis with concomitant heart failure portends a significantly worse prognosis in both preserved and reduced left ventricular ejection fraction.
V. Truong   +6 more
semanticscholar   +1 more source

Sarcopenia and Heart Failure [PDF]

open access: yesNutrients, 2020
Modifications of lean mass are a frequent critical determinant in the pathophysiology and progression of heart failure (HF). Sarcopenia may be considered one of the most important causes of low physical performance and reduced cardiorespiratory fitness in older patients with HF. Sarcopenia is frequently misdiagnosed as cachexia. However, muscle wasting
Francesco Cacciatore   +14 more
openaire   +4 more sources

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

open access: yesEuropean Journal of Heart Failure, 2022
Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P. Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor Aboyans (France), Stamatis Adamopoulos (Greece), Stefan D.
T. McDonagh   +30 more
semanticscholar   +1 more source

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

open access: yesNew England Journal of Medicine, 2020
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.
M. Packer   +38 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy